Ads
related to: Prostate Cancer, Cell and Cancer Cells- EGFRm mNSCLC Progression
What's Next When Patients Progress
On EGFR-TKIs? Visit Site For Info.
- Addressing The Unmet Need
Learn About The Unmet Need For
Options That Can Improve Outcomes
- View Possible Approaches
See The Need For Additional Options
In EGFRm mNSCLC. Learn More.
- A New Line Of Thinking
For When EGFR-TKI Resistance Leads
To Progression in mNSCLC. Read More
- EGFRm mNSCLC Progression
Search results
Assetmark Inc. Boosts Stock Position in BeiGene, Ltd. (NASDAQ:BGNE)
ETF DAILY NEWS· 6 days agoAssetmark Inc. boosted its holdings in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) by 13.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange ...
BioNTech SE (NASDAQ:BNTX) Shares Sold by Robeco Institutional Asset Management B.V.
ETF DAILY NEWS· 6 days agoRobeco Institutional Asset Management B.V. lowered its position in BioNTech SE (NASDAQ:BNTX – Free Report) by 18.8% in the fourth quarter, HoldingsChannel reports. The fund owned 110,790 shares ...
Alpha Tau Medical Ltd. to Post Q2 2025 Earnings of ($0.13) Per Share, HC Wainwright Forecasts...
ETF DAILY NEWS· 7 days agoAlpha Tau Medical Ltd. (NASDAQ:DRTS – Free Report) – HC Wainwright issued their Q2 2025 earnings per share estimates for shares of Alpha Tau Medical in a research report issued on Wednesday, ...
